Withus Pharmaceutical, 19.5 Billion KRW Facility Investment

[Asia Economy Reporter Minwoo Lee] Withus Pharmaceutical announced on the 23rd that it has decided to invest 19.5 billion KRW in new facility investment and factory construction to produce long-acting injectable drugs for hair loss treatment and to diversify its injectable drug business. This amount corresponds to 25.37% of the company's equity capital based on consolidated financials from last year.

Withus Pharmaceutical explained, "We will build a dedicated microfluidic factory and an automated logistics warehouse with a total area of 2,228 pyeong, consisting of one basement floor and seven above-ground floors, on the existing Anseong factory site."